TNNI3 and Stroke: Our studies show the HCG device is useful for rapid (4 minutes) and quantitative determinations of cTnI in PBS and in mock serum samples over a concentration range that is relevant for clinical analysis of cTnI in the serum of stroke victims (100 pg/ml to 80 μg/ml)17.